Clicky

Adaptive Biotechnologies Corporation(ADPT) News

Date Title
Jul 24 Adaptive Biotechnologies' (NASDAQ:ADPT) investors will be pleased with their strong 161% return over the last year
Jul 22 Adaptive Biotechnologies Corporation (ADPT) Rose on Solid Results
Jul 15 Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025
Jul 1 Adaptive Biotechnologies and Flatiron Health Announce Integration of clonoSEQ® MRD Testing into OncoEMR®
Jun 26 Adaptive Biotechnologies (ADPT) Surges 12.5%: Is This an Indication of Further Gains?
Jun 25 Craig-Hallum Initiates Coverage of Adaptive Biotechnologies (ADPT) stock, Gives Buy
Jun 25 Is Bio-Techne Stock Underperforming the Nasdaq?
Jun 13 What Makes Adaptive Biotechnologies (ADPT) a New Buy Stock
May 26 Is Adaptive Biotechnologies (ADPT) Outperforming Other Medical Stocks This Year?
Mar 11 Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma
Jan 17 Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year?
Jan 16 Adaptive Biotechnologies (ADPT) Soars 18.0%: Is Further Upside Left in the Stock?
Jan 2 Adaptive Biotechnologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Jan 1 Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?
Nov 1 November 2024's Top US Penny Stocks With Growth Potential
Aug 29 Adaptive Announces IVDR Certification for clonoSEQ® in European Union
Jul 29 Strong week for Adaptive Biotechnologies (NASDAQ:ADPT) shareholders doesn't alleviate pain of three-year loss
May 31 Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
May 29 Adaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
May 9 Adaptive Biotechnologies First Quarter 2024 Earnings: Beats Expectations